Director/PDMR Shareholding

About this update from Cambridge Nutritional Sciences Plc

Cambridge Nutritional Sciences plc (the 'Company' or 'CNS')   Director/PDMR Shareholding   CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition,   announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 150,000 ordinary shares of 4 pence each in the Company (" Ordinary Shares "), at an average price of 2.32 pence each. Jeremy Millard, Non-Executive Director of the Company, has also purchased 168,776 Ordinary Shares in the Company, at a price of 2.37 pence each.   A summary of Carolyn Rand and Jeremy Millard's resultant holdings is below:   Director Board Position Number of Ordinary Shares acquired Total beneficial holding of Ordinary Shares following this acquisition Number of Ordinary Shares Approximate % of Company's issued share capital Carolyn Rand Non-Executive Chair 150,000 347,500 0.14% Jeremy Millard Non-Executive Director 168,776 1,193,776 0.50%     Contacts:    Cambridge Nutritional Sciences plc     www.cnsplc.com Carolyn Rand, Non-Executive Chair James Cooper, Interim Chief Executive Cavendish Capital Markets Limited     Tel: 020 7220 0500 Geoff Nash / Edward Whiley (Corporate Finance) Nigel Birks / Harriet Ward (ECM)   About Cambridge Nutritional Sciences plc Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist   medical diagnostics company focused on industry-leading Health and Nutrition products.     Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them   1 Details of the person discharging managerial responsibilities / person closely associated a) Name Carolyn Rand 2 Reason for the notification a) Position/status Non-Executive Chair b)   Initial notification /Amendment   Initial Notification 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Cambridge Nutritional Sciences plc b) LEI 2138007U9P4BTZTYIR92 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a)   Description of the financial instrument, type of instrument   Identification code Ordinary Shares of 4 pence each         ISIN: GB00B1VCP282 b)   Nature of the transaction Ordinary Shares purchased c) Price(s) and volume(s)   Price(s) Volume(s) 2.30 pence 100,000 2.365 pence 50,000 d)   Aggregated information     -Aggregated volume     - Price       Aggregated volume - 150,000       Price - 2.3216 e)   Date of the transaction 18.11.2025 f)   Place of the transaction London Stock Exchange   1 Details of the person discharging managerial responsibilities / person closely associated a) Name Jeremy Millard 2 Reason for the notification a) Position/status Non-Executive Director b)   Initial notification /Amendment Initial Notification 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Cambridge Nutritional Sciences plc b) LEI 2138007U9P4BTZTYIR92 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted     a)   Description of the financial instrument, type of instrument   Identification code Ordinary Shares of 4 pence each         ISIN: GB00B1VCP282 b)   Nature of the transaction Ordinary Shares purchased c) Price(s) and volume(s)   Price(s) Volume(s) 2.37 pence 168,776 d)   Aggregated information     -Aggregated volume     - Price       As above. e)   Date of the transaction 18.11.2025 f)   Place of the transaction London Stock Exchange  

View stock analysis, news, and events for Cambridge Nutritional Sciences Plc